Pillstats
Rx only · Tablet · Oral

Nebivolol

Nebivolol Hydrochloride

19 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US76 NDCs
19 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCC07AB12
RxCUI (US)31555
US makers19 labelers
Packages189
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 72 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.041$0.081$0.122$0.162Dec 2025Apr 2026Jul 2026
$0.140
Latest avg · Jul 22, 2026
+0%
Since Dec 17, 2025
19
Active US suppliers
21%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

15K30K44K59K2025 Q12025 Q22025 Q32025 Q42026 Q1
48K
Rx · 2026 Q1
2.4M
Units dispensed
+7%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it19 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Bryant Ranch Prepackrepackager21SUPPLYING
Camber Pharmaceuticals, Inc.unknown19SUPPLYING
Modavar Pharmaceuticals LLCunknown16SUPPLYING
Novadoz Pharmaceuticals LLCunknown16SUPPLYING
Cadila Pharmaceuticals Limitedunknown16SUPPLYING
Ascend Laboratories, LLCunknown16SUPPLYING
Solco Healthcare US, LLCunknown12SUPPLYING
Macleods Pharmaceuticals Limitedunknown12SUPPLYING
ANI Pharmaceuticals, Inc.unknown11SUPPLYING
A-S Medication Solutionsunknown10SUPPLYING
Aurobindo Pharma Limitedunknown8SUPPLYING
NorthStar RxLLCunknown7SUPPLYING
Lifestar Pharma LLCunknown7SUPPLYING
Golden State Medical Supply, Inc.unknown7SUPPLYING
Major Pharmaceuticalsunknown4SUPPLYING

+ 4 more labelers

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Dec 6, 2024
    RECALLRecall (Class II): Nebivolol Tablets, 2.5. mg, 30-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hights…

    CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso Nebivolol above acceptable intake (AI) limit. — Recalling firm: Aurobindo Pharma USA Inc — Nationwide in the USA